PhRMA
SEPTEMBER 1, 2022
There’s been a lot of discussion this year about the Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) for new Alzheimer’s treatments finalized earlier this year in April. Their policy, finalized this past April, puts in place barriers between Alzheimer’s patients in Medicare and potentially life-changing treatment.
Drug Topics
SEPTEMBER 1, 2022
Survey participants said their drug costs have gone up and almost a third had trouble paying for food and housing because of high drug costs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
SEPTEMBER 1, 2022
Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacy technicians can face burnout and advocate for themselves.
Drug Topics
SEPTEMBER 1, 2022
This recall of propofol because of particulates seen in vials follows a previous one in July 2022.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
SEPTEMBER 1, 2022
Though around 42% of medical students in study experience headaches, many of these causing significant functional disability, most choose to self-manage symptoms with sleep and medication.
Drug Topics
SEPTEMBER 1, 2022
Findings show more than one-third of infected preschoolers are asymptomatic. The results call into question COVID-19 prevention strategies based on screening young children for symptoms.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Store News
SEPTEMBER 1, 2022
Seventy percent of pharmacists who responded to EnlivenHealth's survey said that a third or more of their pharmacy's revenue comes from Medicare-eligible patients.
STAT
SEPTEMBER 1, 2022
As the country heads for its third autumn and winter with Covid-19, the forecasts are not auspicious. Given how transmissible the SARS-CoV-2 virus is, models anticipate more than 100,000 additional deaths by the time next summer rolls around. The toll will depend on whether new variants emerge and how humans behave. Will many Americans, for example, decide to get the new, Omicron-tailored booster that could be available as soon as this weekend?
Drug Store News
SEPTEMBER 1, 2022
The membership warehouse club has revealed that its net sales climbed 15.3% to top $70.8 billion and shoppers rang up $222.7 billion in net sales, a 15.9% increase from fiscal 2021.
Pharmacy Times
SEPTEMBER 1, 2022
Study results show that the risk of gaining 10% or more of body weight from the baseline fell 50% when patients were on the combination.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
SEPTEMBER 1, 2022
Walmart and Sustainable Beef will work collaboratively to increase visibility in the beef supply chain and help ranchers grow their business.
Pharmacy Times
SEPTEMBER 1, 2022
Georgia State University analysis supports new strategy for creating these vaccines, investigators contend.
pharmaphorum
SEPTEMBER 1, 2022
AstraZeneca has succeeded in a last-gasp effort to stop its former head of investor relations joining rival UK pharma group GSK, after winning an injunction in the High Court in London. Chris Sheldon ended an almost 19-year career at AZ in August, working his way up from a lab role and holding a series of senior positions at the company, most recently as head of investor relations.
STAT
SEPTEMBER 1, 2022
Maria Van Kerkhove gets it. Truly, she knows you’re over Covid. The World Health Organization’s technical lead for Covid-19, Van Kerkhove understands that the world is struggling with a lot right now. Devastating flooding in Pakistan, famine in the Horn of Africa, war in Ukraine, monkeypox around the globe — there are too many demands for our attention and concern, for philanthropic and government funding.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
SEPTEMBER 1, 2022
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. COVID-19 antiviral medications Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) must be taken within five days of the onset of symptoms, but obtaining these medications within that window is difficult for some.
STAT
SEPTEMBER 1, 2022
Much of the public’s perceptions around food as an intervention for health are dated. So are the U.S. government’s perceptions and its health care policies. Not by a matter of years, but by decades. The last time the nation focused on food — from the top — was the 1969 White House Conference on Food, Nutrition, and Health.
PharmaVoice
SEPTEMBER 1, 2022
A long-time analyst, Tycho Peterson brings his business savvy to the C-suite at Adaptive, where he began as CFO in June with a knowledge of what works and what doesn't in the diagnostics space.
STAT
SEPTEMBER 1, 2022
An expert committee that advises the Centers for Disease Control and Prevention on vaccine policy voted on Thursday to recommend use of updated Covid-19 vaccines. With the positive votes from the Advisory Committee on Immunization Practices, the issue now goes to CDC Director Rochelle Walensky. If she signs off on the recommendation — and she is expected to do so, possibly Thursday evening — the new boosters will be cleared for use.
Drug Store News
SEPTEMBER 1, 2022
Generic Sprycel is indicated for adults with a certain type of chronic myeloid leukemia and generic Pristiq is used to treat depression.
STAT
SEPTEMBER 1, 2022
Covid-19 pummeled public health agencies and organizations. Future crises, whether from infectious disease, extreme weather, or other sources, are likely to do the same unless they change their approach to public health reporting, data management, and information exchange. Managing public health is not easy, especially in the United States. Not only is this country home to diverse populations that have varying genetic predispositions and cultural patterns of medical significance, it is also geog
Pharmacy Times
SEPTEMBER 1, 2022
School-aged children that self-swabbed for COVID-19 did so with almost as much accuracy as a health care provider, which could ease strain on school health care systems.
STAT
SEPTEMBER 1, 2022
What can worms teach us about immortality? How does one become the Godfather? And where does Biogen go from here? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the scientific discoveries, rampant hype, and Silicon Valley billions behind the burgeoning field of longevity research.
Pharmacy Times
SEPTEMBER 1, 2022
Viral DNA samples from 4 ancient cadavers suggest that HSV-1 transmission boomed with Bronze Age migrations and the introduction of kissing as a romantic and sexual cultural practice.
STAT
SEPTEMBER 1, 2022
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired for $8 billion last year. An administrative law judge rejected the FTC’s argument that the San Diego company’s acquisition of Grail would quash competition in the nascent market for multi-cancer early detection, a technology that picks up on a wide range of cancer types
Pharmacy Times
SEPTEMBER 1, 2022
Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.
STAT
SEPTEMBER 1, 2022
Good morning. This is Jonathan with you once more. We’re now close enough to the weekend that it’s time to start making plans (or looking forward to the ones you’ve made), but far enough that there’s still plenty of work to do. Oh, the agony. Hope these engaging news items help ease the pain. The Food and Drug Administration authorized new Covid booster shots that more closely match the strains of the coronavirus currently circulating in the U.S., STAT tells us.
Pharmacy Times
SEPTEMBER 1, 2022
Zynrelef is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.
STAT
SEPTEMBER 1, 2022
In 2021, Jennifer Huberty left her post in academia to become the first full-time head of science at Calm. She set about building a team to beef up the multibillion dollar meditation app’s bonafides, hiring researchers from Harvard, Brown, and other prestigious institutions. A year later, Huberty has departed the company to strike out on her own as a scientific consultant for digital health companies, and the future of her science team and the company’s broader research efforts is
Drug Store News
SEPTEMBER 1, 2022
Amorepacific has entered into a definitive agreement to acquire Tata Harper.
Pharmaceutical Technology
SEPTEMBER 1, 2022
Guardant Health has extended a partnership with Merck KGaA, Darmstadt, Germany, to aid in expediting precision oncology therapeutics development. Under the collaboration, the companies will use the GuardantINFORM real-world evidence (RWE) platform to boost works for developing Merck’s precision cancer pipeline. The development of therapies for key oncology indications with substantial unmet needs will be the expanded partnership’s focus.
Pharmacy Times
SEPTEMBER 1, 2022
Rina Shah, PharmD, discussed the growing role for pharmacists in encouraging holistic health and wellness for patients.
pharmaphorum
SEPTEMBER 1, 2022
Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive Fiona Marshall. Novartis said this morning that Bradner (pictured above left) – who is also stepping down from the executive committee – is leaving to “pursue a next chapter of scientific contribution and leadership” outside the company.
Pharmacy Times
SEPTEMBER 1, 2022
Although it may not have immediate significant impacts for many patients, the Inflation Reduction Act could open the door for future changes.
PharmExec
SEPTEMBER 1, 2022
In episode 116, Dr. Greg Rippon, vice president and chief medical partner at Genentech, discusses his work in Alzheimer’s and his outlook for the future of the therapeutic space.
Expert insights. Personalized for you.
200 
Let's personalize your content